Relmada Therapeutics, Inc.
RLMDNASDAQHealthcareBiotechnology
As of Oct 22, 2026 close
- Market cap
- $369.72M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $1.98$8.00
- Volume (live)
- -
- Avg. volume (3M)
- 1.47M
Relmada Therapeutics (RLMD) Stock Price & Financial Analysis
Relmada Therapeutics Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $3.15 - $3.41 |
|---|---|
| 52-Week High | $8.00 |
| 52-Week Low | $1.98 |
| Open | $3.27 |
| Volume (last close) | 6.28M |
| Average Volume (3M) | 1.47M |
| 50-Day MA | $4.07 |
|---|---|
| 200-Day MA | $5.39 |
| 1-Year Change | +48.87% |
| Market Cap | 369.72M |
|---|---|
| Shares Outstanding | 112.38M |
| Price to Book (P/B) | 1.79 |
| EV/EBITDA | -5.72 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 22, 2026. Data sources and methodology
Relmada Therapeutics at a Glance
As of the Oct 22, 2026 close, Relmada Therapeutics (RLMD) has a market capitalization of $369.72M.
As of its latest reported balance sheet, it holds $11.33M in cash and securities against $0.00 of debt, a net cash position of $11.33M.
Relmada Therapeutics does not currently pay a dividend.
The share price is up 48.9% over the past year. At $3.29 (the Oct 22, 2026 close) it sits within its 52-week range of $1.98 to $8.00, below its 200-day moving average of $5.39.
Frequently Asked Questions About Relmada Therapeutics
What is the current stock price for RLMD?
As of the Oct 22, 2026 close, RLMD stock trades at $3.29. The 52-week range is $1.98–$8.00, with a day range of $3.15–$3.41.
What is the P/E ratio for RLMD?
The P/E ratio (Price-to-Earnings) for RLMD is shown in the Key Statistics section. This valuation metric helps compare Relmada Therapeutics, Inc. to industry peers.
Does RLMD pay dividends?
Relmada Therapeutics does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for RLMD?
Analyst ratings and recommendations for RLMD are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of RLMD?
As of the Oct 22, 2026 close, Relmada Therapeutics's market capitalization is $369.7M, classifying it as a small-cap company. Relmada Therapeutics operates in the Healthcare sector within the Biotechnology industry.